Long dedicated to patient advocacy, Dr. Charvin has served as an advisor for several biotech companies.
PARIS, FRANCE, September 08, 2021 /24-7PressRelease/ -- Delphine Charvin has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Having accrued nearly two decades of inimitable expertise in her chosen field, Dr. Charvin has garnered a laudable reputation as an expert at scientific strategy at various biotech companies. Currently serving as the Partner Science for Argobio Studio, it is her duty to identify and assess new technologies to create and develop pioneering biotech spinouts, as well as design the corporate strategy for incubated projects from a scientific point of view. In the past, Dr. Charvin has held positions at Lundbeck as chief scientific officer from 2018 to 2020, as well as Merck Serono as a senior scientist and project leader.
Dr. Charvin's exemplary performance in the field was born of her academic journey, during which time she finished her undergraduate studies at Université d'Evry Val d'Essonne and earned a Bachelor of Science in Genetics and Bioinformatics in 2001. She furthered her education at Sorbonne Université, and received a Master of Science in 2002 in neuroscience, as well as a Doctor of Philosophy in 2005, also in neuroscience. Her PhD has been awarded by summa cum laude and she received the national annual award from the French Society of Neuroscience for a thesis demonstrating excellence and promise. Dr. Charvin would conclude her education with a post-doctorate at Ecole Polytechnique Fédérale de Lausanne in Switzerland in 2007 before venturing into the corporate sphere.
Long dedicated to patient advocacy, Dr. Charvin has served as an advisor for several biotech companies, through her own consultancy firm, Mindeed Consulting. Well regarded for her scholarly output, she has authored several publications throughout her career, including "Therapeutic Strategies for Parkinson Disease: Beyond Dopaminergic Drugs" published in 2018 for Nature Reviews Drug Discovery. In the future, Dr. Charvin hopes to further distinguish herself in an entrepreneurial role, and build a new biotech company that focuses on innovative treatments to improve the quality of life of patients.
About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #